EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Advancements and Uncertainties in the Treatment of Congenital CMV Disease

Yarlini Vipulanandan iD, David W Kimberlin

Reviews in Medical Virology · 2026

DOI: 10.1002/rmv.70093 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Reviews in Medical Virology, 2026. Verfasst von Yarlini Vipulanandan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Antiviral Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Congenital cytomegalovirus (CMV) is a large contributor to neurodevelopmental delay and non‐genetic related sensorineural hearing loss, which can often be delayed in onset. While a majority of CMV infections are asymptomatic in healthy children and adults, CMV infection of immunocompromised hosts and in utero infection in neonates can cause more clinically significant and potentially long‐term disease. Increased awareness of the significance of congenital CMV is reflected in the evolution of treatment recommendations over the past 20 years. Most therapeutic studies conducted thus far have focused on the treatment and outcomes of neonates with moderate to severe congenital CMV disease, while more recent studies have explored treatment for neonates and infants with CMV‐related isolated sensorineural hearing loss. This review focuses on the clinical significance and treatment of congenital CMV infection, as well as the potential role for universal newborn CMV screening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytomegalovirus InfectionsAntiviral AgentsHumansInfant, NewbornHearing Loss, SensorineuralCytomegalovirusNeonatal ScreeningPregnancyPregnancy Complications, Infectious

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.

ORCID-Profile: Yarlini Vipulanandan

Zitieren

APA

Vipulanandan, Y., & Kimberlin, D. W. (2026). Advancements and Uncertainties in the Treatment of Congenital CMV Disease. Reviews in Medical Virology. https://doi.org/10.1002/rmv.70093

Vancouver

Vipulanandan Y, Kimberlin DW. Advancements and Uncertainties in the Treatment of Congenital CMV Disease. Reviews in Medical Virology. 2026. doi:10.1002/rmv.70093

BibTeX
@article{Vipulanandan2026,
  author = {Vipulanandan, Yarlini and Kimberlin, David W},
  title = {Advancements and Uncertainties in the Treatment of Congenital CMV Disease},
  journal = {Reviews in Medical Virology},
  year = {2026},
  doi = {10.1002/rmv.70093}
}
Kostenlos starten →